Table 3 Characteristics of the study population stratified by the presence or absence of previous diabetes mellitus (DM)
From: Association between inpatient glycemic variability and COVID-19 mortality: a prospective study
Entire cohort (n) | Patients without DM | Patients with DM | p values | |
|---|---|---|---|---|
Patients—n (%) | 628 (100%) | 422 (67.2%) | 206 (32.8%) | N/A |
Age (years)—mean (± SD) | 59.62 ± 15.9 | 57.11 ± 16.23 | 64.75 ± 13.88 | < 0.001 |
Male sex (%) | 413 (65.8%) | 238 (66.7%) | 175 (64.6%) | 0.532 |
Comorbidities | ||||
Hypertension | 328 (52.2%) | 187 (44.3%) | 141 (68.4%) | < 0.001 |
Cardiovascular disease | 85 (13.5%) | 40 (9.5%) | 45 (21.8%) | < 0.001 |
Cerebrovascular disease | 21 (3.34%) | 11 (2.6%) | 10 (4.9%) | 0.159 |
Chronic kidney disease | 24 (3.8%) | 12 (2.8%) | 12 (5.8%) | 0.078 |
Malignancy | 27 (4.3%) | 19 (4.5%) | 8 (3.9%) | 0.836 |
Dyslipidemia | 174 (27.7%) | 82 (19.4%) | 92 (44.7%) | < 0.001 |
Obesity* | 200 (n = 625) (32%) | 136 (32%) | 65 (31.6%) | 1 |
Pulmonary disease | 55 (8.8%) | 40 (9.5%) | 15 (7.3%) | 0.452 |
Outpatient insulin use | 18 (2.9%) | 0 | 18 (8.7%) | N/A |
Dexamethasone use** | 586 (93.3%) | 397 (94.1%) | 189 (91.7%) | 0.308 |
Outcome | ||||
Hypoglycemia | 59 (9.4%) | 30 (7.1%) | 29 (14.1%) | 0.008 |
Mortality | 131 (20.9%) | 82 (19.4%) | 49 (23.8%) | 0.211 |